Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

BeOne Medicines (BEIGF) Non-Current Assets (2016 - 2025)

BeOne Medicines (BEIGF) has disclosed Non-Current Assets for 11 consecutive years, with $2.0 billion as the latest value for Q4 2025.

  • Quarterly Non-Current Assets rose 1.33% to $2.0 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.0 billion through Dec 2025, up 1.33% year-over-year, with the annual reading at $2.0 billion for FY2025, 1.33% up from the prior year.
  • Non-Current Assets for Q4 2025 was $2.0 billion at BeOne Medicines, down from $2.0 billion in the prior quarter.
  • The five-year high for Non-Current Assets was $2.0 billion in Q2 2025, with the low at $680.0 million in Q1 2021.
  • Average Non-Current Assets over 5 years is $1.4 billion, with a median of $1.4 billion recorded in 2023.
  • The sharpest move saw Non-Current Assets soared 57.82% in 2022, then grew 1.33% in 2025.
  • Over 5 years, Non-Current Assets stood at $921.6 million in 2021, then grew by 27.19% to $1.2 billion in 2022, then surged by 36.65% to $1.6 billion in 2023, then grew by 20.44% to $1.9 billion in 2024, then grew by 1.33% to $2.0 billion in 2025.
  • According to Business Quant data, Non-Current Assets over the past three periods came in at $2.0 billion, $2.0 billion, and $2.0 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.